Gilead Sciences, Inc (NASDAQ:GILD) shares, rose in value, with the stock price up by 0.93% to the previous day’s close as strong demand from buyers drove the stock to $114.29.
Actively observing the price movement in the recent trading, the stock is buoying the session at $113.24, falling within a range of $112.8301 and $114.69. The value of beta (5-year monthly) is 0.311 whereas the PE ratio is 24.03 over 12-month period. Referring to stock’s 52-week performance, its high was $119.96, and the low was $67.65. On the whole, GILD has fluctuated by 1.14% over the past month.
With the market capitalization of Gilead Sciences, Inc currently standing at about $142.17 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-24. The company’s Forward Dividend Ratio is 3.12, with its dividend yield at 2.73%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 28.67B, with a low estimate of 6.74B and a high estimate of 7.27B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 6.95B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that GILD’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0.92, with the price of GILD currently trading nearly 3.88% and 6.45% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 63.34, while the 7-day volatility ratio is showing 1.65% which for the 30-day chart, stands at 2.30%. Furthermore, Gilead Sciences, Inc (GILD)’s beta value is 0.35.
A comparison of Gilead Sciences, Inc (GILD) with its peers suggests the former has fared considerably weaker in the market. GILD showed an intraday change of 0.93% in today’s session so far, and over the past year, it grew by 23.73%%.
Data on historical trading for Gilead Sciences, Inc (NASDAQ:GILD) indicates that the trading volumes over the past 10 days have averaged 7.31 and over the past 3 months, they’ve averaged 8.64 million. According to company’s latest data on outstanding shares, there are 1.25 billion shares outstanding.
Nearly 0.16% of Gilead Sciences, Inc’s shares belong to company insiders and institutional investors own 86.80% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 22.99 million shares as on 2025-06-13, resulting in a short ratio of 2.85. According to the data, the short interest in Gilead Sciences, Inc (GILD) stood at 185.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 24.68 million. The stock has risen by 69.19% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GILD stock heading into the next quarter.
